Citigroup’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Citigroup’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1	Closed	-$4	–	5836
2024 Q2	$4	Buy	+1	New	+$5	﹤0.01%	5534
2024 Q1	–	Hold	0	–	–	–	5596
2023 Q4	–	Hold	0	–	–	–	5667
2023 Q3	–	Hold	0	–	–	–	5624
2023 Q2	–	Hold	0	–	–	–	5521
2023 Q1	–	Sell	-9	Closed	-$319	–	5380
2022 Q4	$205	Sell	9 -19	-68%	-$516	﹤0.01%	5596
2022 Q3	$1K	Sell	28 -10	-26%	-$352	﹤0.01%	5711
2022 Q2	$1K	Sell	38 -41	-52%	-$2.83K	﹤0.01%	6125
2022 Q1	$8K	Sell	79 -79	-50%	-$12K	﹤0.01%	5649
2021 Q4	$31K	Buy	158 +109	+222%	+$17K	﹤0.01%	5257
2021 Q3	$10K	Buy	+49	New	+$12.4K	﹤0.01%	5475

Other funds holding TBIO

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Citigroup's TBIO Position: Q3 2024 in Review

Citigroup sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2024, closing a stake of 1 share — an estimated $4 sold.

Citigroup first reported a position in TBIO in Q3 2021 and held it in 7 quarters. The position peaked at $31K in Q4 2021. 1 fund tracked by Wall St. Rank holds TBIO as of Q3 2024.

Citigroup reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Citigroup sold 1 Telesis Bio, Inc. Common Stock share in Q3 2024, an estimated $4.
Citigroup first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Citigroup's Telesis Bio, Inc. Common Stock position peaked at $31K in Q4 2021.
1 fund tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2024.

Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.